MAS receptor agonists are a class of compounds that target and activate the MAS receptor, which is a G protein-coupled receptor involved in the regulation of cardiovascular and renal functions. These agonists have shown potential in the treatment of conditions such as hypertension, heart failure, and kidney disease by promoting vasodilation, reducing inflammation, and improving renal function. Research in this area is focused on developing new MAS receptor agonists with improved pharmacological properties and exploring their potential therapeutic benefits in various cardiovascular and renal disorders.